BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/18/2020 5:58:43 AM | Browse: 646 | Download: 1045
 |
Received |
|
2020-07-28 22:05 |
 |
Peer-Review Started |
|
2020-07-28 22:06 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2020-09-17 17:14 |
 |
Revised |
|
2020-09-29 16:01 |
 |
Second Decision |
|
2020-10-21 12:53 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2020-10-21 16:48 |
 |
Articles in Press |
|
2020-10-21 16:48 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2020-10-31 23:41 |
 |
Typeset the Manuscript |
|
2020-12-10 02:45 |
 |
Publish the Manuscript Online |
|
2020-12-18 05:58 |
ISSN |
1948-5182 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Surgery |
Manuscript Type |
Case Report |
Article Title |
Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report
|
Manuscript Source |
Invited Manuscript |
All Author List |
Hideki Yokoo, Hiroyuki Takahashi, Masahiro Hagiwara, Hiroyoshi Iwata, Koji Imai, Yoshinori Saito, Naoto Matsuno and Hiroyuki Furukawa |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Hideki Yokoo, MD, PhD, Associate Professor, Division of Hepato-Biliary-Pancreatic Surgery and Transplant Surgery, Department of Surgery, Asahikawa Medical University, 2-1 Midorigaoka-Higashi, Asahikawa 078-8510, Hokkaido, Japan. hidekiyokoo@asahikawa-med.ac.jp |
Key Words |
Conversion to surgery; Lenvatinib; Recurrent hepatocellular carcinoma; Case report; Neoadjuvant therapy; Molecular targeted therapy |
Core Tip |
Lenvatinib was shown to be noninferior to sorafenib for unresectable hepatocellular carcinoma (HCC), and tumor shrinkage was observed in ~40% of cases. We report a case of intrahepatic HCC recurrence with rapid growth and sternal bone metastases after initial resection of HCC, in which conversion to second surgery was successfully achieved after lenvatinib administration induced tumor shrinkage. Regarding histopathological findings, 80% of the tumor was necrotic and the resected margin of the liver surface showed no cancer component. Tumor marker PIVKA-II decreased to the normal range after surgery. Because the patient had bone metastases, multidisciplinary therapy, postoperative radiation therapy, and lenvatinib administration were performed, and the patient remains alive at 1 year postoperatively. In this case, lenvatinib induced a partial response for rapid growth of recurrent HCC with bone metastases, and conversion to surgery was successfully achieved for the purpose of controlling the intrahepatic lesion for the first time. |
Publish Date |
2020-12-18 05:58 |
Citation |
Yokoo H, Takahashi H, Hagiwara M, Iwata H, Imai K, Saito Y, Matsuno N, Furukawa H. Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report. World J Hepatol 2020; 12(12): 1349-1357 |
URL |
https://www.wjgnet.com/1948-5182/full/v12/i12/1349.htm |
DOI |
https://dx.doi.org/10.4254/wjh.v12.i12.1349 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345